Eyenovia Inc (EYEN)
1.01
+0.07
(+7.74%)
USD |
NASDAQ |
May 03, 16:00
1.02
+0.01
(+0.99%)
After-Hours: 20:00
Eyenovia Cash from Operations (TTM): -23.84M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -23.84M |
September 30, 2023 | -22.92M |
June 30, 2023 | -23.90M |
March 31, 2023 | -23.88M |
December 31, 2022 | -25.11M |
September 30, 2022 | -25.58M |
June 30, 2022 | -23.85M |
March 31, 2022 | -24.48M |
December 31, 2021 | -20.87M |
September 30, 2021 | -9.529M |
June 30, 2021 | -6.371M |
March 31, 2021 | -5.040M |
December 31, 2020 | -6.384M |
Date | Value |
---|---|
September 30, 2020 | -15.87M |
June 30, 2020 | -17.80M |
March 31, 2020 | -18.94M |
December 31, 2019 | -18.92M |
September 30, 2019 | -19.00M |
June 30, 2019 | -18.72M |
March 31, 2019 | -16.62M |
December 31, 2018 | -13.11M |
September 30, 2018 | -11.00M |
June 30, 2018 | -8.249M |
March 31, 2018 | -6.253M |
December 31, 2017 | -4.731M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-25.58M
Minimum
Sep 2022
-5.040M
Maximum
Mar 2021
-18.47M
Average
-19.00M
Median
Sep 2019
Cash from Operations (TTM) Benchmarks
NovaBay Pharmaceuticals Inc | -4.131M |
Alpine Immune Sciences Inc | -79.01M |
Lantern Pharma Inc | -14.35M |
Oragenics Inc | -7.291M |
MAIA Biotechnology Inc | -13.07M |